130 related articles for article (PubMed ID: 23863262)
41. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
42. Characteristics and surgical outcome of HCC patients with low platelet count.
Kondo K; Chijiiwa Y; Otani K; Kai M; Ohuchida J; Chijiiwa K
Hepatogastroenterology; 2012 Oct; 59(119):2269-72. PubMed ID: 23435142
[TBL] [Abstract][Full Text] [Related]
43. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
44. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
Duvoux C; Roudot-Thoraval F; Decaens T; Pessione F; Badran H; Piardi T; Francoz C; Compagnon P; Vanlemmens C; Dumortier J; Dharancy S; Gugenheim J; Bernard PH; Adam R; Radenne S; Muscari F; Conti F; Hardwigsen J; Pageaux GP; Chazouillères O; Salame E; Hilleret MN; Lebray P; Abergel A; Debette-Gratien M; Kluger MD; Mallat A; Azoulay D; Cherqui D;
Gastroenterology; 2012 Oct; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
[TBL] [Abstract][Full Text] [Related]
45. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.
Lee CH; Lin YJ; Lin CC; Yen CL; Shen CH; Chang CJ; Hsieh SY
Liver Int; 2015 Oct; 35(10):2327-36. PubMed ID: 25752212
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
[TBL] [Abstract][Full Text] [Related]
47. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
48. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
49. A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.
Xia Y; Yan ZL; Xi T; Wang K; Li J; Shi LH; Wu MC; Shen F
Hepatogastroenterology; 2012 Oct; 59(119):2248-54. PubMed ID: 22366528
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006
[TBL] [Abstract][Full Text] [Related]
51. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Takayama H; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jul; 26(7):1195-200. PubMed ID: 21410750
[TBL] [Abstract][Full Text] [Related]
52. Small hepatocellular carcinomas and thrombocytopenia.
Carr BI; Guerra V; De Giorgio M; Fagiuoli S; Pancoska P
Oncology; 2012; 83(6):331-8. PubMed ID: 23006906
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Zhang JB; Chen Y; Zhang B; Xie X; Zhang L; Ge N; Ren Z; Ye SL
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):787-93. PubMed ID: 21730869
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
[TBL] [Abstract][Full Text] [Related]
55. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
[TBL] [Abstract][Full Text] [Related]
56. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
[TBL] [Abstract][Full Text] [Related]
57. A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.
Carr BI; Guerra V
Oncology; 2016; 90(4):215-20. PubMed ID: 26974336
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis status, child-pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma.
Reichman TW; Bahramipour P; Barone A; Koneru B; Fisher A; Contractor D; Wilson D; Dela Torre A; Cho KC; Samanta A; Harrison LE
J Gastrointest Surg; 2005; 9(5):638-45. PubMed ID: 15862257
[TBL] [Abstract][Full Text] [Related]
59. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
[TBL] [Abstract][Full Text] [Related]
60. Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.
Han HJ; Kim MS; Cha J; Choi JS; Han KH; Seong J
Oncology; 2014; 87 Suppl 1():82-9. PubMed ID: 25427738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
